au.\*:("SEGAL, Michal F")
Results 1 to 1 of 1
Selection :
A Phase 2 Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor MK-0646 in Patients With Metastatic, Well-Differentiated Neuroendocrine TumorsREIDY-LAGUNES, Diane L; VAKIANI, Efsevia; SEGAL, Michal F et al.Cancer. 2012, Vol 118, Num 19, pp 4795-4800, issn 0008-543X, 6 p.Article